Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
| 50 | 3 | PSYCHIATRY//SCHIZOPHRENIA//PSYCHIAT | 98837 |
| 347 | 2 | ANTIDEPRESSANTS//PSYCHIATRY//DEPRESSION | 18063 |
| 31251 | 1 | VORTIOXETINE//LU AA21004//EXTERNAL SOURCING SCI EXCELLENCE | 170 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | VORTIOXETINE | authKW | 9953058 | 44% | 73% | 74 |
| 2 | LU AA21004 | authKW | 2607098 | 9% | 94% | 15 |
| 3 | EXTERNAL SOURCING SCI EXCELLENCE | address | 825840 | 4% | 64% | 7 |
| 4 | CLIN QUANTITAT PHARMACOL | address | 593258 | 2% | 80% | 4 |
| 5 | MULTIMODAL ANTIDEPRESSANT | authKW | 494381 | 2% | 67% | 4 |
| 6 | BRINTELLIX | authKW | 417134 | 2% | 75% | 3 |
| 7 | BIS ARYL SULFANYLA MINE | authKW | 370787 | 1% | 100% | 2 |
| 8 | CNS MED | address | 370787 | 1% | 100% | 2 |
| 9 | VORTIOXETINE HYDROBROMIDE | authKW | 370787 | 1% | 100% | 2 |
| 10 | 5 AXIS TEMPLATE | authKW | 185394 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Psychiatry | 2623 | 45% | 0% | 76 |
| 2 | Pharmacology & Pharmacy | 1628 | 56% | 0% | 96 |
| 3 | Clinical Neurology | 876 | 32% | 0% | 54 |
| 4 | Neurosciences | 474 | 32% | 0% | 54 |
| 5 | Psychology, Clinical | 32 | 4% | 0% | 6 |
| 6 | Chemistry, Analytical | 23 | 6% | 0% | 11 |
| 7 | Toxicology | 21 | 4% | 0% | 7 |
| 8 | Nursing | 21 | 2% | 0% | 4 |
| 9 | Biochemical Research Methods | 15 | 4% | 0% | 7 |
| 10 | Health Policy & Services | 14 | 2% | 0% | 3 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EXTERNAL SOURCING SCI EXCELLENCE | 825840 | 4% | 64% | 7 |
| 2 | CLIN QUANTITAT PHARMACOL | 593258 | 2% | 80% | 4 |
| 3 | CNS MED | 370787 | 1% | 100% | 2 |
| 4 | CNS STAT | 185394 | 1% | 100% | 1 |
| 5 | CNS STATPHARMACOVIGILANCE | 185394 | 1% | 100% | 1 |
| 6 | EQUIPE DEP S ANTIDEP SEURS MED PARIS SU | 185394 | 1% | 100% | 1 |
| 7 | INSERM UMR S SANTE MENTALE SANTE PUBL 1178 | 185394 | 1% | 100% | 1 |
| 8 | INSERMSANTE MENTALE SANTE PUBL U1178 | 185394 | 1% | 100% | 1 |
| 9 | LANGONE MED BEHAV HLTH PROGRAMSPEARL BARLOW | 185394 | 1% | 100% | 1 |
| 10 | MED AFFAIRS MOOD ANXIETY | 185394 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | 15541 | 8% | 1% | 14 |
| 2 | CNS SPECTRUMS | 13426 | 5% | 1% | 9 |
| 3 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 6486 | 5% | 0% | 8 |
| 4 | JOURNAL OF PSYCHOPHARMACOLOGY | 5012 | 5% | 0% | 8 |
| 5 | RIVISTA DI PSICHIATRIA | 3669 | 2% | 1% | 3 |
| 6 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2724 | 3% | 0% | 5 |
| 7 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2485 | 3% | 0% | 5 |
| 8 | JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES | 2419 | 2% | 0% | 3 |
| 9 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 1598 | 2% | 0% | 4 |
| 10 | JOURNAL OF WILDERNESS MEDICINE | 1446 | 1% | 1% | 1 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VORTIOXETINE | 9953058 | 44% | 73% | 74 | Search VORTIOXETINE | Search VORTIOXETINE |
| 2 | LU AA21004 | 2607098 | 9% | 94% | 15 | Search LU+AA21004 | Search LU+AA21004 |
| 3 | MULTIMODAL ANTIDEPRESSANT | 494381 | 2% | 67% | 4 | Search MULTIMODAL+ANTIDEPRESSANT | Search MULTIMODAL+ANTIDEPRESSANT |
| 4 | BRINTELLIX | 417134 | 2% | 75% | 3 | Search BRINTELLIX | Search BRINTELLIX |
| 5 | BIS ARYL SULFANYLA MINE | 370787 | 1% | 100% | 2 | Search BIS+ARYL+SULFANYLA+MINE | Search BIS+ARYL+SULFANYLA+MINE |
| 6 | VORTIOXETINE HYDROBROMIDE | 370787 | 1% | 100% | 2 | Search VORTIOXETINE+HYDROBROMIDE | Search VORTIOXETINE+HYDROBROMIDE |
| 7 | 5 AXIS TEMPLATE | 185394 | 1% | 100% | 1 | Search 5+AXIS+TEMPLATE | Search 5+AXIS+TEMPLATE |
| 8 | 5HT1B D | 185394 | 1% | 100% | 1 | Search 5HT1B+D | Search 5HT1B+D |
| 9 | ADVERSE EFFECTS SIDE EFFECTS SAFETY | 185394 | 1% | 100% | 1 | Search ADVERSE+EFFECTS+SIDE+EFFECTS+SAFETY | Search ADVERSE+EFFECTS+SIDE+EFFECTS+SAFETY |
| 10 | BREO ELLIPTA | 185394 | 1% | 100% | 1 | Search BREO+ELLIPTA | Search BREO+ELLIPTA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |